Ajanta Pharma Limited has informed the Exchange about Copy of Newspaper Publication
AJANTPHARM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Ajanta Pharma has submitted copies of newspaper clippings of its financial results for the quarter ended 30th September 2025 (Q2 FY26) to the stock exchanges. The results were published in the Mumbai editions of Business Standard and Navakal on 4th November 2025. This filing is being made under Regulation 47 of SEBI's Listing Regulations, which requires listed companies to publish their quarterly financial results in newspapers. The letter was signed by Gaurang Shah, Sr. VP – Legal & Company Secretary. This is a routine regulatory compliance disclosure and does not contain any new financial information beyond what was already filed with the exchanges earlier.
No material impact on shareholders or stock price. This is a standard compliance filing confirming that the company's already-disclosed Q2 FY26 results were published in newspapers as required by SEBI rules.